Evaluation of sexual functional status and consistency of scales in patients with hypogonadotropic hypogonadism before and after testosterone replacement therapy: a single-center experience
- PMID: 36468923
- PMCID: PMC10689042
- DOI: 10.20945/2359-3997000000539
Evaluation of sexual functional status and consistency of scales in patients with hypogonadotropic hypogonadism before and after testosterone replacement therapy: a single-center experience
Abstract
Objective: This study aimed to investigate the frequency of sexual dysfunction and the effect of short-term testosterone replacement therapy on sexual functions in congenital hypogonadism patients. Furthermore, we sought to reveal the consistency of the self-report scales used for the diagnosis of sexual dysfunction and the relationship between biochemical parameters.
Materials and methods: The study was conducted on 47 young male patients aged above 18 years who were diagnosed with hypogonadotropic hypogonadism. Short (IIEF-5) and long (IIEF-15) forms of the International Index of Erectile Function and Arizona Sexual Experiences Scale (ASEX) were applied before treatment under the supervision of a physician. The patients' blood pressure, height, and weight were measured, and their luteinizing hormone (LH), FSH, and total testosterone levels were recorded. Patients who started their treatments were called for a follow-up checkup after 6 months. Their blood pressure, height, and weight were measured by reapplying the ASEX, IIEF-5, and IIEF-15. In addition, their LH, FSH, and total testosterone levels in the biochemical tests were rerecorded.
Results: In this study, the sexual dysfunction status of patients diagnosed with hypogonadotropic hypogonadism before and after treatment was evaluated using the ASEX, IIEF-15, and IIEF-5 scales. A decrease in sexual dysfunction was observed in all three scales after treatment compared with that before treatment. The IIEF-5 and IIEF-15 scales were found to be uncorrelated in terms of the pretreatment values but were correlated in terms of the post-treatment values. Although a correlation was observed between ASEX and IIEF- 5 before treatment, no correlation was detected between ASEX and IIEF-15. After the treatment, ASEX was found to be correlated with both IIEF-5 and IIEF-15. The results of the scales indicated the correlation in all categories, except the pretreatment results of the IIEF-15 scale.
Conclusion: The results of the current study demonstrated a significant improvement in the sexual function of hypogonadism patients undergoing short-term testosterone therapy. The ASEX, IIEF-5, and IIEF-15 scales used in the diagnosis and follow-up of sexual dysfunction were useful for evaluating sexual functions in hypogonadotropic hypogonadism patients.
Keywords: Hypogonadotropic hypogonadism; sexual functions; testosterone replacement therapy.
Conflict of interest statement
Disclosure: no potential conflict of interest relevant to this article was reported.
Figures



Similar articles
-
Increased frequency of anxiety, depression, quality of life and sexual life in young hypogonadotropic hypogonadal males and impacts of testosterone replacement therapy on these conditions.Endocr J. 2012;59(12):1099-105. doi: 10.1507/endocrj.ej12-0134. Epub 2012 Aug 31. Endocr J. 2012. PMID: 22972022
-
Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores.Eur Urol. 2017 Dec;72(6):1000-1011. doi: 10.1016/j.eururo.2017.03.032. Epub 2017 Apr 20. Eur Urol. 2017. PMID: 28434676 Review.
-
CLOMIPHENE CITRATE IN THE TREATMENT OF IDIOPATHIC OR FUNCTIONAL HYPOGONADOTROPIC HYPOGONADISM IN MEN: A CASE SERIES AND REVIEW OF THE LITERATURE.Endocr Pract. 2017 Mar;23(3):279-287. doi: 10.4158/EP161543.OR. Epub 2016 Nov 16. Endocr Pract. 2017. PMID: 27849376
-
Androgen receptor gene CAG repeat polymorphism independently influences recovery of male sexual function after testosterone replacement therapy in postsurgical hypogonadotropic hypogonadism.J Sex Med. 2014 May;11(5):1302-8. doi: 10.1111/jsm.12493. Epub 2014 Mar 4. J Sex Med. 2014. PMID: 24593124
-
Hypogonadotropic hypogonadism in men with type 2 diabetes.Postgrad Med. 2009 May;121(3):45-51. doi: 10.3810/pgm.2009.05.2001. Postgrad Med. 2009. PMID: 19491539 Review.
References
-
- Swerdloff RS, Wang C. Goldman-Cecil Medicine . 25th ed. Philadelphia, PA: Elsevier Saunders; 2016. The testis and male hypogonadism, infertility, and sexual dysfunction.
-
- Adrenal ve Gonadal Hastalıklar Kılavuzu Türkiye Endokrinoloji ve Metabolizma Derne-i Yayınları . 2019:105–105.
-
- Conte HR. Development and use of self-report techniques for assessing sexual functioning: a review and critique. Arch Sex Behav . 1983;12(6):555–576. - PubMed
-
- McGahuey CA, Gelenberg AJ, Laukes CA, Moreno FA, Delgado PL, McKnight KM, et al. The Arizona sexual experience scale (ASEX): reliability and validity. J Sex Marital Ther . 2000;26(1):25–40. - PubMed
-
- Soykan A. The reliability and validity of Arizona Sexual Experiences Scale in Turkish ESRD patients undergoing hemodialysis. Int J Impot Res . 2004;16(6):531–534. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical